| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.2 |